Filed: 11/14/2024ACC: 0001104659-24-118283
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $123.46M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$123.46M
Total AUM (reported)
13.95M
Total Shares
Allocation by class
COM$88.62M71.8%
COM PAR $.01$7.85M6.4%
SPONSORED ADR$6.33M5.1%
COMMON STOCK$5.19M4.2%
SPON ADS$5.18M4.2%
COM SHS$4.26M3.4%
SPONSORED ADS$2.43M2.0%
Portfolio Concentration
Top 3$34.36M27.8%
4–10$41.67M33.8%
11–25$39.63M32.1%
Rest$7.80M6.3%
Top 3 weight
27.8%
Top 10 weight
61.6%
Voting Authority Distribution
Total shares with voting rights: 13.95M
Sole
Full voting authority
13.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
VAXCYTE INC
SOLEShares135.40K
TypeSH
Market value$15.47M
12.53%
Sole
135.40K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.19M
TypeSH
Market value$10.35M
8.39%
Sole
1.19M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares332.10K
TypeSH
Market value$8.54M
6.92%
Sole
332.10K
Shared
0.00
None
0.00
INSMED INC
SOLEShares107.50K
TypeSH
Market value$7.85M
6.36%
Sole
107.50K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares296.37K
TypeSH
Market value$7.57M
6.13%
Sole
296.37K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares131.70K
TypeSH
Market value$6.73M
5.45%
Sole
131.70K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares62.10K
TypeSH
Market value$5.19M
4.20%
Sole
62.10K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares1.26M
TypeSH
Market value$5.18M
4.20%
Sole
1.26M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares108K
TypeSH
Market value$4.90M
3.97%
Sole
108K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares2.12M
TypeSH
Market value$4.26M
3.45%
Sole
2.12M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares487K
TypeSH
Market value$4.06M
3.29%
Sole
487K
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares197K
TypeSH
Market value$3.85M
3.12%
Sole
197K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$3.81M
3.09%
Sole
1.85M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares190K
TypeSH
Market value$3.51M
2.84%
Sole
190K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares57.50K
TypeSH
Market value$3.31M
2.68%
Sole
57.50K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares5.90K
TypeSH
Market value$3.20M
2.59%
Sole
5.90K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares21K
TypeSH
Market value$3.14M
2.54%
Sole
21K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares386.50K
TypeSH
Market value$2.43M
1.97%
Sole
386.50K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares1.20M
TypeSH
Market value$2.27M
1.84%
Sole
1.20M
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares180.94K
TypeSH
Market value$1.89M
1.53%
Sole
180.94K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares364K
TypeSH
Market value$1.79M
1.45%
Sole
364K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares63K
TypeSH
Market value$1.68M
1.36%
Sole
63K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares46.20K
TypeSH
Market value$1.66M
1.34%
Sole
46.20K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares19.50K
TypeSH
Market value$1.63M
1.32%
Sole
19.50K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL INC
SOLEShares25.10K
TypeSH
Market value$1.39M
1.13%
Sole
25.10K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VAXCYTE INCSOLE | COM | 135.40K | SH | $15.47M 12.53% | 135.40K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.19M | SH | $10.35M 8.39% | 1.19M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 332.10K | SH | $8.54M 6.92% | 332.10K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 107.50K | SH | $7.85M 6.36% | 107.50K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 296.37K | SH | $7.57M 6.13% | 296.37K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 131.70K | SH | $6.73M 5.45% | 131.70K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 62.10K | SH | $5.19M 4.20% | 62.10K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 1.26M | SH | $5.18M 4.20% | 1.26M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 108K | SH | $4.90M 3.97% | 108K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 2.12M | SH | $4.26M 3.45% | 2.12M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 487K | SH | $4.06M 3.29% | 487K | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 197K | SH | $3.85M 3.12% | 197K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $3.81M 3.09% | 1.85M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 190K | SH | $3.51M 2.84% | 190K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 57.50K | SH | $3.31M 2.68% | 57.50K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 5.90K | SH | $3.20M 2.59% | 5.90K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 21K | SH | $3.14M 2.54% | 21K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 386.50K | SH | $2.43M 1.97% | 386.50K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 1.20M | SH | $2.27M 1.84% | 1.20M | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 180.94K | SH | $1.89M 1.53% | 180.94K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 364K | SH | $1.79M 1.45% | 364K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 63K | SH | $1.68M 1.36% | 63K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 46.20K | SH | $1.66M 1.34% | 46.20K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 19.50K | SH | $1.63M 1.32% | 19.50K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INCSOLE | COM | 25.10K | SH | $1.39M 1.13% | 25.10K | 0.00 | 0.00 |
Page 1 of 2